Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
06/2010
06/09/2010CN101240024B Single-chain antibody scFv of hBAFF and application thereof in producing BAFF human source monoclonal antibody
06/08/2010US7732588 Expression vector comprising nucleotide sequences coding tumor necrosis factor receptor protein (TWEAK) for mediated by angiogenesis, such as solid tumors and vascular deficiencies of cardiac or peripheral tissue
06/08/2010US7732584 Exhibits tissue specific expression in normal adult tissue, and is aberrantly expressed in cancers; provides a diagnostic, prognostic, prophylactic and/or therapeutic target for cancer
06/08/2010US7732579 High-affinity monoclonal antibodies for botulinum toxin type A
06/08/2010US7732578 Selecting variable region framework sequences from human antibody genes by comparing canonical CDR structure types for corresponding CDRs from a library of human germline antibody sequences; converting an antibody sequence of any subject species to a less immunogenic form
06/08/2010US7732577 Isolated antibody specific for a mammalian MDM2 binding protein comprising SEQ ID No. 2 or 4
06/08/2010US7732576 for identification on human chromosome 10 of a tumor suppressor gene;
06/08/2010US7732570 Alteration of Fc-fusion protein serum half-lives by mutagenesis
06/08/2010US7732566 a protein originating from latex that can induce an allergic reaction in persons sensitized to the protein
06/08/2010US7732377 Methods for producing members of specific binding pairs
06/08/2010US7732164 Method for producing α-1, 6-branched α-1, 4-glucans from sucrose
06/08/2010US7732156 accurate and sensitive direct sandwich assay; diagnosing pathological cartilage degeneration based upon detection of biomarkers
06/08/2010US7732154 analyses on the relationship between diabetes and free insulin receptor alpha -subunit in the living body; diagnosing diabetes and cancer
06/08/2010US7732147 Using muscle specific tyrosine kinase as autoantibody screening tool and evaluative indicator of myasthenia gravis
06/08/2010US7732146 Method for screening an agent that modulates activity of macrophage migration inhibitory factor
06/08/2010US7732132 hybridoma cell line that produces a monoclonal antibody against the NSs proteins of WSMoV-serogroup tospoviruses
06/08/2010US7731995 Methods for using soy peptides to inhibit H3 acetylation, reduce expression of HMG CoA reductase, and increase LDL receptor and Sp1 expression in a mammal
06/08/2010US7731970 Variants of the major allergen Phl p 1 from timothy grass
06/08/2010US7731966 Monoclonal antibodies against β3 integrins
06/08/2010US7731964 Comprises immunoglobulin which binds insulin receptors when phosphorylated at serine 1101 and/or 1149; for diagnosing insulin-resistance diabetes and insulin transport disorders
06/08/2010US7731963 modulating angiogenesis and inhibiting tumor progression by using TWEAK receptor (Fn14) agonists
06/08/2010US7731962 Anti-ADDL monoclonal antibody and use thereof
06/08/2010US7731961 Methods of increasing muscle mass or muscle strength using antibody inhibitors of GDF-8
06/08/2010CA2388063C Cytotoxic agents comprising taxanes and their therapeutic use
06/08/2010CA2363991C Anti-idiotypic antibodies against antibodies which inhibit the binding of immunoglobuline to its high affinity receptor
06/08/2010CA2158047C Allergenic protein and peptides from house dust mite and uses therefor
06/03/2010WO2010062857A1 Klk-13 antibody inhibitor for treating dry eye
06/03/2010WO2010062663A1 Inflammatory bowel disease biomarkers and related methods of treatment
06/03/2010WO2010062244A1 Aqueous two phase extraction augmented precipitation process for purification of therapeutic proteins
06/03/2010WO2010061991A1 Vegf-specific human antibody
06/03/2010WO2010061892A1 Novel variable lymphocyte receptor, method for screening for phage capable of binding to target antigen, and method for producing variable lymphocyte receptor for target antigen
06/03/2010WO2010061393A1 He4 variant nucleotide and amino acid sequences, and methods of use thereof
06/03/2010WO2010060995A1 Use of basic prolin-rich lacrimal gene products, such as opiorphin, as a biomarker
06/03/2010WO2010060972A1 Erk1/2 phosphorylation site specific antibody
06/03/2010WO2010060768A1 Polypeptides, antibody variable domains & antagonists
06/03/2010WO2010060486A1 Ligands that bind il-13
06/03/2010WO2010060217A1 Antibody-targeted carrier for contrast agents
06/03/2010WO2010060216A1 Nanoaggregate embedded beads conjugated to single domain antibodies
06/03/2010WO2010060209A1 Single domain antibody - targeted nanoparticle architectures for increased pathogen detection specificity and sensitivity
06/03/2010WO2010060186A1 Antibodies that specifically block the biological activity of a tumor antigen
06/03/2010WO2010040105A3 Cd86 antagonist multi-target binding proteins
06/03/2010WO2010006060A3 Prostaglandin e2 dual variable domain immunoglobulins and uses thereof
06/03/2010WO2009134805A3 Antibodies to granulocyte-macrophage colony-stimulating factor
06/03/2010WO2009126688A8 Novel compositions and methods for the treatment of immune related diseases
06/03/2010WO2009114335A3 Pd-1 binding proteins
06/03/2010WO2009080764A3 Oral or nasal administration of compounds comprising amino acid sequences
06/03/2010US20100138945 Humanized anti-il-6 antibodies
06/03/2010US20100138942 Use of the augmenter of liver regeneration protein as an apoptosis regulator
06/03/2010US20100138941 Method for screening immune modulator
06/03/2010US20100137564 Polypeptide of n-acetylglucosamine-6-o-sulfotransferase and dna encoding the same
06/03/2010US20100137557 Use of one or more metal carriers to selectively kill mammalian cells
06/03/2010US20100137420 Methods and Compositions for Diagnosis and Treatment of Multiple Sclerosis
06/03/2010US20100137219 Methods and Compositions for Inhibiting Binding IgE to a High Affinity Receptor
06/03/2010US20100137218 Expression System of NELL Peptide
06/03/2010US20100136710 RNA processing protein complexes and uses thereof
06/03/2010US20100136684 Natural IgM Antibodies
06/03/2010US20100136660 Methods for producing members of specific binding pairs
06/03/2010US20100136652 Molecular Conjugate
06/03/2010US20100136627 Engineered Rabbit Antibody Variable Domains and Uses Thereof
06/03/2010US20100136626 Production and Use of Novel Peptide-Based Agents for Use with Bi-Specific Antibodies
06/03/2010US20100136625 Method for the high level expression of active lymphotoxin-beta receptor immunoglobulin chimeric proteins and their purification
06/03/2010US20100136624 Method for making monoclonal antibodies and cross-reactive antibodies obtainable by the method
06/03/2010US20100136623 Mutations in ion channels
06/03/2010US20100136590 Method of Determining NT-proBNP
06/03/2010US20100136581 Diagnosis and treatment of malignant neoplasms
06/03/2010US20100136576 In Vitro Method for Diagnosing Prostate Cancer
06/03/2010US20100136575 B7-related nucleic acids and polypeptides useful for immunomodulation
06/03/2010US20100136573 Diagnosing neurodegenerative diseases
06/03/2010US20100136571 I-plastin assay method for the in vitro diagnosis of colorectal cancer
06/03/2010US20100136539 Ezrin assay method for the in vitro diagnosis of colorectal cancer
06/03/2010US20100136528 Fiat nucleic acids and proteins and uses thereof
06/03/2010US20100136527 Dominant B Cell Epitopes and Methods of Making and Using Thereof
06/03/2010US20100136526 Therapeutic Agent for Neuroblastoma Targeting ARID3b
06/03/2010US20100136522 Endogenous retroviruses up-regulated in prostate cancer
06/03/2010US20100136518 Antibodies useful for therapy and diagnosis of cancer
06/03/2010US20100136113 Phytases, nucleic acids encoding them and methods for making and using them
06/03/2010US20100136057 Virulence of streptococci
06/03/2010US20100136055 Chimeric pestiviruses
06/03/2010US20100136052 Replication deficient influenza virus for the expression of heterologous sequences
06/03/2010US20100136039 Borrelia antigens
06/03/2010US20100136036 Unconventional antigen translated by a novel internal ribosome entry site elicits antitumor humoral immune reactions
06/03/2010US20100136033 METHODS OF TREATMENT USING ANTI-ErbB ANTIBODY-MAYTANSINOID CONJUGATES
06/03/2010US20100136032 Trimeric ox40-immunoglobulin fusion protein and methods of use
06/03/2010US20100136030 Antagonist ox40 antibodies and their use in the treatment of inflammatory and autoimmune diseases
06/03/2010US20100136028 Antagonists of pcsk9
06/03/2010US20100136027 Methods and Compositions for Treating Bacterial Infection
06/03/2010US20100136024 Selective Inhibition of Histone Deacetylase 6 for Ocular Neuroprotection or for Treatment or Control of Glaucoma
06/03/2010US20100136021 Tgf-beta binding antibodies
06/03/2010US20100136020 Uses of il-174 antagonists for inhibiting a th2 immune response
06/03/2010US20100136018 Anti-FC-receptor single domain antibodies (nanobodies-tm) and therapeutic use
06/03/2010US20100136017 Diagnostic tumor markers, drug screening for tumorigenesis inhibition, and compositions and methods for treatment of cancer
06/03/2010US20100136016 Heat shock proteins from mycobacterium leprae and uses thereof
06/03/2010US20100136015 Methods and compositions for regulating iron homeostasis by modulation of bmp-6
06/03/2010US20100136014 GIPs, a Family of Polypeptides with Transcription Factor Activity that Interact with Goodpasture Antigen Binding Protein
06/03/2010US20100136013 Cd55-interaction partners and the uses thereof
06/03/2010US20100136012 Variants of vegfr and their use in the diagnosis and treatment of pregnancy associated medical conditions
06/03/2010US20100136011 Antibodies that bind to obm
06/03/2010US20100136010 Novel 27875, 22025, 27420, 17906, 16319, 55092 and 10218 molecules and uses therefor
06/03/2010US20100136009 OVR110 Antibody Compositions and Methods of Use
06/03/2010US20100136008 TACI-Fc Fusion Proteins, Methods of Making and Uses Thereof
1 ... 358 359 360 361 362 363 364 365 366 367 368 369 370 371 372 373 374 375 376 377 378 ... 1494